P028: Improved neurocognitive outcomes in neuronopathic mucopolysaccharidosis type II: A case of early hematopoietic stem cell transplant

P028: Improved neurocognitive outcomes in neuronopathic mucopolysaccharidosis type II: A case of early hematopoietic stem cell transplant

Bibliographic Details
Main Authors:	Emma Michl, Benjamin Goodlett, Christine Duncan, Olaf Bodamer
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423000389

Similar Items

Hematopoietic Stem Cell Transplantation in Mucopolysaccharidosis Type II
by: Anneliese L. Barth MD, PhD, et al.
Published: (2018-05-01)

Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment
by: Karen S. Yee, et al.
Published: (2024-04-01)

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data
by: Roberto Giugliani, et al.
Published: (2021-10-01)

Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation
by: Yasuyuki Suzuki, et al.
Published: (2020-01-01)

Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course
by: Joo-Hyun Seo, et al.
Published: (2020-09-01)

Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up
by: Anneliese L. Barth, et al.
Published: (2017-09-01)

Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II
by: Karen S. Yee, et al.
Published: (2024-03-01)

O01: Outcomes of newborn screening for mucopolysaccharidosis type I: Boston Children’s Hospital single center experience*
by: Aishwarya Siddharth, et al.
Published: (2023-01-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
by: Yuhua Qu, et al.
Published: (2022-06-01)

Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS)
by: Olaf Bodamer, et al.
Published: (2017-06-01)

A post hoc analysis of Projected Retained Ability Scores (PRAS) for the longitudinal assessment of cognitive functioning in patients with neuronopathic mucopolysaccharidosis II receiving intrathecal idursulfase-IT
by: Karen S. Yee, et al.
Published: (2023-11-01)

Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases
by: Karolina Wiśniewska, et al.
Published: (2024-03-01)

Toileting Abilities Survey as a surrogate outcome measure for cognitive function: Findings from neuronopathic mucopolysaccharidosis II patients treated with idursulfase and intrathecal idursulfase
by: Melissa J. Hogan, et al.
Published: (2020-12-01)

Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease
by: Aimee Donald, et al.
Published: (2022-06-01)

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
by: Ryuji Yamamoto, et al.
Published: (2021-06-01)

Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in aspartylglucosaminuria: A case series
by: Arthavan Selvanathan, et al.
Published: (2021-09-01)

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
by: Rita Barone, et al.
Published: (2018-11-01)

“Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients”
by: Alessandro Cattoni, et al.
Published: (2021-09-01)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
by: Kleopatra Pericleous, et al.
Published: (2023-09-01)

Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study
by: Yuta Koto, et al.
Published: (2023-09-01)

Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation
by: Luis M. Carbajal-Rodríguez, et al.
Published: (2021-08-01)

Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group
by: Anja F. Köhn, et al.
Published: (2020-06-01)

P001: Single center experience with the Massachusetts State Newborn Screening Pilot Program for mucopolysaccharidosis type I, Pompe disease and X-linked adrenoleukodystrophy
by: Christina Grassie, et al.
Published: (2023-01-01)

028 EARLY CRRT IN A POST KIDNEY TRANSPLANTATION PATIENT WITH SEPTIC SHOCK
by: S.A.N.D.H.I. PRABOWO, et al.
Published: (2017-08-01)

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure
by: Sykora Karl-Walter, et al.
Published: (2011-08-01)

Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art
by: María José de Castro, et al.
Published: (2021-08-01)

Neuronopathic Types of Mucopolysaccharidoses: Pathogenesis and Emerging Treatments
by: L. A. Osipova, et al.
Published: (2015-11-01)

Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
by: Nathan Grant
Published: (2020-03-01)

Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
by: Nohela B. Arévalo, et al.
Published: (2022-08-01)

Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients
by: Akhil Bhalla, et al.
Published: (2020-07-01)

Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome
by: Viktoriia Sofronova, et al.
Published: (2022-05-01)

Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse.
by: Ying Sun, et al.
Published: (2011-04-01)

Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
by: J.B. Eisengart, et al.
Published: (2020-03-01)

Hematopoietic stem cell transplantation
by: Eleftheria Hatzimichael, et al.
Published: (2010-08-01)

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
by: Scarpa Maurizio, et al.
Published: (2011-11-01)

Predictors of growth patterns in children with mucopolysaccharidosis I after haematopoietic stem cell transplantation
by: Stefanie Maier, et al.
Published: (2022-07-01)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
by: Galina Baydakova, et al.
Published: (2020-03-01)

Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)

Case study of two Iraqi patients with Mucopolysaccharidosis (Hurler syndrome "type I" and Maroteaux-Lamy syndrome "type VI") treated with Hematopoietic Stem Cell Transplantation (HSCT)
by: Furqan M. Abdulelah, et al.
Published: (2023-01-01)

Pediatric Hematopoietic Stem Cell Transplantation
by: Gaurav Kharya, et al.
Published: (2015-01-01)